Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: J Hepatol. 2008 Apr 14;49(1):134–142. doi: 10.1016/j.jhep.2008.03.012

Table 1.

Selected transgenic mouse models expressing HCV proteins and liver pathology.

Transgene and promoter Liver phenotype Reference

Core HBV Steatosis Perlemuter et al. 2002 [25]
HCC Moriya et al. 1998 [29]
Oxidative stress Moriya et al. 2001 [30]
Alteration of cytokine expression Tsutsumi et al. 2002 [41]
Activation of retinoid X receptor alpha Tsutsumi et al. 2002 [46]
Steatosis, HCC Moriishi et al. 2007 [26]
Tanaka et al. 2008 [49]
Tanaka et al. 2008 [50]
EF-1α Oxidative stress Machida et al. 2006 [53]

Core-E1-E2 Albumin Steatosis, HCC Lerat et al. 2002 [32]
HCC Kamegaya et al. 2005 [34]
Oxidative stress Okuda et al. 2002 [54]
Korenaga et al. 2005 [55]
CMV Steatosis, HCC Naas et al. 2005 [92]

Core-E1-E2-NS2 Cre-loxP system Hepatitis, Cellular immune responses Wakita et al. 1998 [61]
Wakita et al. 2000 [62]
Suppression of Fas-mediated cell death Machida et al. 2001 [63]

Polyprotein Alpha1 antitrypsin Steatosis, intrahepatic Alonzi et al. 2004 [93]
T cell recruitment
Albumin Steatosis, HCC Lerat et al. 2002 [32]
Impairment of cellular immune response Disson et al. 2004 [59]